Numico, the Dutch food group, has dropped a broad hint that it iswilling to listen to merger plans, especially from pharmaceutical firms. The group's chief executive, Hans van der Wielen, named Novartis, American Home Products and Bristol-Myers Squibb in an interview with the Dutch newspaper NRC Handelsblad as potential partners.
No merger talks have been held as yet, but numerous investment bankers have paid Numico a visit to discuss possible link-ups. Mr van der Wielen told the newspaper that if the firm "could form a combination with one of the three.....we would get a world organization."
Numico says it is undervalued
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze